Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.